Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: MythMan who wrote (60271)	1/22/2001 8:34:57 AM
From: Lucretius	Respond to of 436258

no, not till i have covered at $9 -eg-

To: MythMan who wrote (60271)	1/22/2001 9:57:51 AM
From: jj_	Respond to of 436258

FOREIGN MARKETS: The Nikkei closed 0.31% higher while the Hang Seng closed up 1.04%. In Europe, Germany is down 0.59%, France is down 0.29% and the UK is down 0.55%. MOVERS: (CREAF) Creative Technology reported Q2 after the bell of $0.33/share. They BEAT First Call consensus of $0.23/share by $0.10/share. Year-ago was $0.52/share. Revenues fell 2.2% to $427.03 million from a year-ago of $436.79 million.. (DSCM) Drugstore.com announced on Friday, they were eliminating approximately 125 jobs through layoffs and expected attrition as well as reductions in planned marketing expenses. (AMGN) A Federal judge ruled in Amgen’s (AMGN) favor for one of their top-selling drugs and saved their monopoly. The judge ruled that Transkaryotic (TKTX) had infringed on 3 Amgen patents for its erythropoietin drug, which treats anemia by boosting red-blood-cell production. The decision is a blow to Transkaryotic, as they had been developing Erythropoietin, using an unusual new manufacturing method designed to get around existing patent protections. They intend to appeal the ruling. Merrill Keeps Amgen I-T Rating At Accumulate, $72 Goal. Merrill Upgrades Amgen To L-T Buy From Accumulate. First Union Upgrades Amgen To Buy, $91 Target. Morgan Stanley Lifts Amgen To Strong Buy From Outperform. (COVD) Covad and Reliant Energy Communications (REI) broadened their relationship. Reliant will offer DSL powered by Covad to its business customers. (LEFX) LifeFX and IBM enter a licensing agreement. (CELL) Brightpoint entered a services agreement with Handspring (HAND). Under the agreement, will provide procurement, programming, packaging, distribution and other services relating to Handspring's VisorPhone Springboard module, which allows Visor to be used as a mobile phone. (AEOS) American Eagle Outfitters declared a 3-for-2 stock split. Shares will be payable on February 23, 200., (LSI) LSI Logic signed an agreement with IBM. IBM will be using LSI’s digital signal processors in their custom computer chips. (MRCH) CS First Boston reinstate coverage for MarchFirst with a BUY rating and $8 target price. (LXK) Lexmark International reported Q4 of $0.64/share. They BEAT the First Call consensus by $0.03/share. Revenues increased to $1.096 billion, up 9% from the yr-ago SHAKERS: (TKTX) Morgan Stanley Cuts Transkaryotic Thera To Neutral – see AMGN story. (ADCT) WR Hambrecht Clips ADC Telecom Target To $25, Keeps Buy. USB Piper Lowers ADC Telecom To Buy, Cuts Goal To $23. (XOXO) Merrill Clips XO Comm. Target To $50, Reits I-T/L-T Buy. (SDLI) Wit SoundView Lowers SDL Inc. To Buy From Strong Buy. (JDSU) Wit SoundView Cuts JDS Uniphase To Buy From Strong Buy. (PWAV) UBS Warburg Cuts Powerwave To Hold, Clips Target To $51. (DELL) Dell Computer warned this morning for Q4 and said they see a net of $0.18-$0.19/share, much lower than the consensus of $0.25/share. IPO’s: none SPLITS: -Companies trading on a split adjusted basis today - (SWWC) Southwest Water Co., 5 to 4 (TALX) TALX Corp, 3 to 2 -Companies trading on a split adjusted basis Tuesday - none ECONOMIC DATA: -Today- 10:00 AM: Leading Indicators, consensus is -0.3% 2:00 PM: Treasury Budget, consensus is $32.0B